Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP46A1 | Q9Y6A2 | 3/20 | 1.00 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.83 |
| ▸ | POLA1 | P09884 | 1/20 | 0.74 |
| ▸ | OSBP | P22059 | 3/20 | 0.71 |
| ▸ | USP2 | O75604 | 2/20 | 0.71 |
| ▸ | RORC | P51449 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.71 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.71 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.63 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.63 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.63 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.63 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.61 |
| ▸ | GBA1 | P04062 | 2/20 | 0.60 |
| ▸ | UGCG | Q16739 | 2/20 | 0.60 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.60 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL161397 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL3509637 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL2304848 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL192029 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL25063545 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL22077526 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL25063542 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL16248291 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL21334348 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 | |
| SCHEMBL21824301 | 1.00 | CYP46A1 (1.00) | CYP46A1NR1H3POLA1OSBPUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1755 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115129-A1 | METHOD FOR INCREASING EFFECTIVE POLYPHENOL COMPONENTS USING HIGH-TEMPERATURE AND PRESSURIZATION STEAM EXTRACTION METHOD | SUMSUMBIOCO LTD (KR) | 2026-04-30 | — | — | US | claimed |
| US-20250281459-A1 | LIPIDS, FORMULATIONS, AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2025-09-11 | — | — | US | claimed |
| US-20250186339-A1 | COMPOSITION FOR INTRAORAL DELIVERY OF BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS | SCHWARZ JOSEPH (CA) | 2025-06-12 | — | — | US | claimed |
| US-20240269229-A1 | NOVEL LIPOPEPTIDE FORMULATION | ADVAPHARM GMBH (DE) | 2024-08-15 | — | — | US | claimed |
| WO-2023211934-A1 | LIPIDS, FORMULATIONS, AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2023-11-02 | — | — | WO | claimed |
| WO-2023041588-A1 | NOVEL LIPOPEPTIDE FORMULATION | ADVAPHARM GMBH (DE) | 2023-03-23 | — | — | WO | claimed |
| EP-3474953-B1 | SUBSTANCE MIXTURE CONTAINING GLYCOSAMINOGLYCAN, METHOD FOR PRODUCING SAME AND USE OF SAME | FACH DR CHRISTIAN (DE) | 2022-11-16 | — | — | EP | claimed |
| US-20220228171-A1 | COMPOSITIONS AND PRODUCTION OF NICKED CLOSED-ENDED DNA VECTORS | GENERATION BIO CO. | 2022-07-21 | — | — | US | claimed |
| WO-2022153211-A1 | LIPOSOMAL COMPOSITION OF A CAMPTOTHECIN DERIVATIVE | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2022-07-21 | — | — | WO | claimed |
| EP-3999646-A1 | COMPOSITIONS AND PRODUCTION OF NICKED CLOSED-ENDED DNA VECTORS | Generation Bio Co. (US) | 2022-05-25 | — | — | EP | claimed |
| EP-0726761-A1 | MICROPARTICULAR PHARMACEUTICAL COMPOSITIONS IN MICELLAR FORM | ISOTECH MEDICAL, INC. (US) | 1996-08-21 | — | — | EP | claimed |
| EP-0500437-B1 | Ceramides, method for their preparation and their application in cosmetics and dermopharmacy | OREAL (FR) | 1995-07-26 | — | — | EP | claimed |
| WO-1995012385-A1 | MICROPARTICULAR PHARMACEUTICAL COMPOSITIONS IN MICELLAR FORM | ISOTECH MEDICAL, INC. (US) | 1995-05-11 | — | — | WO | claimed |
| EP-0647617-A1 | Ceramides, process for their preparation and their cosmetic uses | L'OREAL (FR) | 1995-04-12 | — | — | EP | claimed |
| EP-0599977-A1 | HIV-TREATMENT METHOD WITH LOW-TOXICITY AMPHOTERICIN B | SEQUUS PHARMACEUTICALS, INC. (a Delaware Corporation) (US) | 1994-06-08 | — | — | EP | claimed |
| EP-0420722-B1 | Lipid compounds, derivatives of sphingosines, process for their preparation and their use, especially in cosmetics and in dermopharmaceutics | OREAL (FR) | 1994-02-23 | — | — | EP | claimed |
| WO-1993003737-A1 | HIV-TREATMENT METHOD WITH LOW-TOXICITY AMPHOTERICIN B | LIPOSOME TECHNOLOGY, INC. (US) | 1993-03-04 | — | — | WO | claimed |
| EP-0500437-A1 | Ceramides, method for their preparation and their application in cosmetics and dermopharmacy | L'OREAL (FR) | 1992-08-26 | — | — | EP | claimed |
| EP-0437577-A1 | TOPICAL DELIVERY OF PEPTIDES/PROTEINS ENTRAPPED IN DEHYDRATION/REHYDRATION LIPOSOMES | THE UNIVERSITY OF MICHIGAN (US) | 1991-07-24 | — | — | EP | claimed |
| WO-1991001719-A1 | TOPICAL DELIVERY OF PEPTIDES/PROTEINS ENTRAPPED IN DEHYDRATION/REHYDRATION LIPOSOMES | THE UNIVERSITY OF MICHIGAN (US) | 1991-02-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250281459-A1 | LIPIDS, FORMULATIONS, AND USES THEREOF | RNMT, INMT, TPH1 | CYP46A1 1053/4885NR1H3 1654/4885POLA1 1117/4885 |
| US-20260115129-A1 | METHOD FOR INCREASING EFFECTIVE POLYPHENOL COMPONENTS USING HIGH-TEMPERATURE AND PRESSURIZATION STEAM EXTRACTION METHOD | TYR, HSF1, NFATC1 | CYP46A1 66/4885NR1H3 3388/4885POLA1 3120/4885 |
| US-20240269229-A1 | NOVEL LIPOPEPTIDE FORMULATION | LPXN, NGLY1, VIP | CYP46A1 1337/4885NR1H3 2243/4885POLA1 4568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.